Pancreatic Cancer Research

ResearcherGeorgia Institute of TechnologyNo recent work listed

Roman Mezencev

Matched on ORCID iD 0000-0003-4361-7628; OpenAlex author ID A5019750782.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 2, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers

Papers 3

  1. Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells. Co-author DOI 10.1038/cgt.2016.23↗
  2. Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes. First author DOI 10.1038/cgt.2016.71↗
  3. Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells. First author DOI 10.1097/cad.0b013e32836009d7↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. John F. McDonald · 3 shared papers, 2013–2016
  2. Roberto Schreiber · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.